•
Jun 30, 2020

CME Group Q2 2020 Earnings Report

CME Group's financial performance reflected resilience amidst the coronavirus pandemic, with increased focus on innovative products and strategic migrations.

Key Takeaways

CME Group reported Q2 2020 financial results with revenue of $1.2 billion and operating income of $638 million. Net income was $503 million, with diluted earnings per share at $1.40. Adjusted net income reached $583 million, and adjusted diluted earnings per share were $1.63.

Markets continued to help clients manage risk and navigate uncertainty during the coronavirus pandemic.

Employees ensured the resiliency of systems and effective operations of markets while working from home.

Innovative new products were delivered, including the reintroduction of 3-Year Treasury Note futures and new options on Micro E-mini Equity futures.

Focus remained on providing increased value to market participants through the migration of the BrokerTec business to CME Globex in Q4.

Total Revenue
$1.18B
Previous year: $1.27B
-7.1%
EPS
$1.63
Previous year: $1.76
-7.4%
Average Daily Volume
17.6M
Average Rate Per Contract
$0.731
Gross Profit
$965M
Previous year: $1.05B
-7.7%
Cash and Equivalents
$1.41B
Previous year: $938M
+49.9%
Free Cash Flow
$950M
Previous year: $401M
+136.9%
Total Assets
$117B
Previous year: $70.3B
+66.6%

CME Group

CME Group

CME Group Revenue by Segment

Forward Guidance

CME Group is committed to promoting the safety of its employees while continuing to facilitate risk transfer and price discovery to help businesses and economies recover from the crisis.

Revenue & Expenses

Visualization of income flow from segment revenue to net income